BME Growth
Labiana |
17 September
Labiana, the Spanish pharmaceutical group specialised in the development, manufacture and commercialisation of medicines for animal and human health, will join the IBEX Growth Market 15, the index comprising the 15 BME Growth-listed companies with the highest free-float-adjusted market capitalisation among those meeting BME’s established liquidity requirements.